U.S. Markets close in 31 mins.

Alexion Pharmaceuticals, Inc. (ALXN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
137.93+4.01 (+2.99%)
As of 3:29PM EDT. Market open.
People also watch
REGNBMRNVRTXBIIBCELG
Full screen
Previous Close133.92
Open134.63
Bid138.71 x 100
Ask138.83 x 100
Day's Range133.40 - 139.00
52 Week Range96.18 - 145.42
Volume1,782,526
Avg. Volume3,170,801
Market Cap30.97B
Beta1.26
PE Ratio (TTM)65.71
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press14 hours ago

    Alexion tops Street 2Q forecasts

    On a per-share basis, the New Haven, Connecticut-based company said it had profit of 73 cents. Earnings, adjusted for one-time gains and costs, were $1.56 per share. The results beat Wall Street expectations. ...

  • Thomson Reuters StreetEvents20 hours ago

    Edited Transcript of ALXN earnings conference call or presentation 27-Jul-17 2:00pm GMT

    Q2 2017 Alexion Pharmaceuticals Inc Earnings Call

  • Barrons.comyesterday

    Alexion: Thank You For Your Patience?

    Shares of Alexion Pharmaceuticals (ALXN) are rising today after the biotech company beat earnings forecasts and raised its guidance. Leerink analyst Geoffrey Porges and Bradley Canino call today's report "the most important" of the large-cap biotech stocks: This morning Alexion announced Q2 revenue of $912mm, which was a 7% beat against consensus of $849mm and an 8% beat vs. our estimate of $846mm (which implied sequentially lower revenue given management’s conservative commentary last quarter and the attrition of patients on Soliris to clinical trials). Shares of Alexion Pharmaceuticals have gained 2% to $133.72 at 12:18 p.m. today, but had been up as much as 8.6% earlier today.